Anti-c-Met/anti-EGFR bispecific antibodies
Abstract:
There are provided an anti-c-Met/anti-EGFR bispecific antibody, a method for treating cancer using the same, and an anti-EGFR scFv fragment.
Public/Granted literature
Information query
Patent Agency Ranking
0/0